Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07830186

Qigong Intervention for Fibromyalgia A Randomized Controlled Study

This randomized controlled pilot study investigates the comparative efficacy of mobility-intensive Qigong exercises versus static posture-based Qigong exercises in patients diagnosed with fibromyalgia. Participants are randomly allocated to either a mobility-intensive Qigong intervention group or a static posture-based Qigong intervention group. The primary objectives are to evaluate improvements in spinal mobility and reductions in pain levels. Secondary outcomes include enhancements in functional exercise capacity, reductions in fatigue severity, and improvements in health-related quality of life. All outcome assessments are conducted at baseline and upon completion of the intervention program.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Age range

30 year–50 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Akdeniz University Hospital, Department of Physical Medicine and Rehabilitation

Antalya, 07070, Turkey (Türkiye)

Location contact

Meryem Aksarı Gedikli, PT, MSc, PhD(c)

CONTACT

[email protected]

+90 531 208 15 15

About this study

Study Rationale and Design:

Fibromyalgia is a chronic musculoskeletal condition characterized by widespread pain, debilitating fatigue, and reduced physical functioning, frequently accompanied by marked limitations in spinal mobility. Mind-body movement modalities such as Qigong demonstrate potential in fibromyalgia rehabilitation; however, comparative evidence elucidating the specific efficacy of dynamic mobility-oriented movement sets versus static posture-based regimens remains sparse.

This study is designed as a double-blind (participants and outcome assessors), two-arm randomized controlled pilot trial. A total of 36 female participants meeting the 2010 American College of Rheumatology (ACR) diagnostic criteria are allocated in a 1:1 ratio using computer-generated simple randomization to one of two active interventions: Mobility-Intensive Qigong (Group 1) or Static Posture-Based Qigong (Group 2). Participants are informed that the trial compares two gentle therapeutic exercise programs to maintain participant blinding, while data analysts and outcome assessors remain fully blinded to group allocation.

Sample Size Determination:

The sample size estimation was determined using Hamidiye Ethics Committee Biostatistics Guidelines and relevant literature referencing pain reduction (McGill Pain Questionnaire) with an effect size of Cohen's d = 1.26. Given the comparison of two active interventions, an anticipated large effect size of d = 1.0 was selected. Setting alpha at 0.05 and statistical power at 80% yielded a minimum required sample of 33 participants. To ensure equal distribution across groups and accommodate potential dropouts, the target sample was finalized at 36 participants.

Intervention Protocol:

Both interventions are delivered online under the live supervision of an experienced physiotherapist and certified Qigong instructor over 12 consecutive weeks (2 sessions per week, 45 minutes per session). Each session comprises 5 minutes of structured warm-up and participant check-in, followed by 40 minutes of protocol-specific Qigong exercises. Group 1 performs dynamic, flowing movements focusing on active multi-segmental joint mobility, muscle lengthening, and breath coordination. Group 2 focuses on sustained isometric postures, focused breath regulation, and static stretching to build postural stability and endurance. Participants who miss a live session are provided structured home-practice guidance; an adherence rate of at least 90% is required for per-protocol analysis.

Assessment Protocol and Settings:

Face-to-face outcome evaluations are carried out at baseline (prior to session 1) and post-intervention at the Akdeniz University Department of Physical Medicine and Rehabilitation in a standardized, climate-controlled setting. Each assessment requires approximately 45 minutes per subject.

  • Primary Clinical Endpoints: Pain intensity and characteristics are quantified using the Short-Form McGill Pain Questionnaire (SF-MPQ, sensory and affective subscales) and a 100-mm Visual Analog Scale (VAS). Spinal mobility across cervical, thoracic, and lumbar segments (flexion, extension, lateral flexion) is measured objectively using an inclinometer.
  • Secondary Clinical Endpoints: Functional exercise capacity is measured using the submaximal 6-Minute Walk Test (6MWT) performed strictly according to 2022 American Thoracic Society (ATS) technical standards. Fatigue severity is assessed via the 9-item Fatigue Severity Scale (FSS), and overall disease-specific functional impact is measured with the Revised Fibromyalgia Impact Questionnaire (FIQR).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female patients aged between 30 and 50 years.
  • Diagnosed with fibromyalgia according to the 2010 American College of Rheumatology (ACR) criteria.
  • Non-obese, defined as Body Mass Index (BMI) < 30 kg/m².
  • Lack of clinical improvement despite receiving pharmacological treatment for more than 3 months.
  • Willingness to adhere to the 12-week supervised online exercise program.

Exclusion criteria

  • Pregnancy or currently breastfeeding.
  • Presence of advanced musculoskeletal pathologies (e.g., inflammatory arthritis, severe osteoarthritis).
  • Diagnosed neurological disorders or peripheral neuropathy.
  • Known severe cardiovascular diseases.
  • History of surgical intervention within the past 4 months.
  • Participation in any regular physical exercise or rehabilitation program within the past 2 months prior to enrollment.

Treatment and study plan

Mobility-Intensive Qigong Exercise

Other

Dynamic and fluid mobility-intensive Qigong exercises focusing on active range of motion, muscle flexibility, muscle strengthening, and breath coordination under online physiotherapist supervision (12 weeks, 2 sessions/week, 45 minutes/session).

Static Posture-Based Qigong Exercise

Other

Participants receive static posture-based Qigong exercises consisting of sustained isometric postures, breath regulation, and alignment control to enhance postural stability, static endurance, and core strengthening under online physiotherapist supervision (12 weeks, 2 sessions/week, 45 minutes/session).

Primary outcomes

  1. Change in Pain Intensity Measured by Visual Analog Scale (VAS)

    Time frame: Baseline and post-intervention at Week 12

    Pain intensity is evaluated using a 100-mm Visual Analog Scale (VAS), where 0 mm indicates "no pain" and 100 mm indicates "unbearable pain." Participants mark their perceived pain intensity on a horizontal 100-mm line. Higher scores represent greater pain severity. Changes from baseline to the end of the 12-week intervention are assessed.

Secondary outcomes

  1. Change in Pain Dimensions Assessed by Short-Form McGill Pain Questionnaire (SF-MPQ)

    Time frame: Baseline and post-intervention at Week 12

    Qualitative and sensory/affective pain dimensions are evaluated using the Short-Form McGill Pain Questionnaire (SF-MPQ). It consists of 15 descriptors (11 sensory, 4 affective) scored on a 4-point intensity scale (0 = none, 1 = mild, 2 = moderate, 3 = severe). The total score ranges from 0 to 45. Higher scores indicate greater pain severity. Changes from baseline to Week 12 are assessed.

  2. Change in Spinal Mobility Measured by Inclinometer

    Time frame: Baseline and post-intervention at Week 12

    Spinal range of motion is evaluated objectively across cervical, thoracic, and lumbar segments (flexion, extension, and lateral flexion) using a digital/bubble inclinometer. Measurements are recorded in degrees (°). Higher values indicate greater range of motion and improved spinal mobility. Changes from baseline to Week 12 post-intervention are assessed.

  3. Change in Fatigue Severity Assessed by Fatigue Severity Scale (FSS)

    Time frame: Baseline and post-intervention at Week 12

    Fatigue severity and its impact on daily activities are evaluated using the 9-item self-report Fatigue Severity Scale (FSS). Items are rated on a 7-point Likert scale from 1 (strongly disagree) to 7 (strongly agree). The total score represents the mean of all items (range: 1 to 7). Higher scores indicate more severe fatigue. Changes from baseline to Week 12 are assessed.

  4. Change in Disease Impact and Quality of Life Measured by Revised Fibromyalgia Impact Questionnaire (FIQR)

    Time frame: Baseline and post-intervention at Week 12

    Disease severity, symptom impact, and health-related quality of life are assessed using the Revised Fibromyalgia Impact Questionnaire (FIQR). The questionnaire comprises 21 questions across three domains (function, overall impact, symptoms) scored on an 11-point numeric scale (0 to 10). The total score ranges from 0 to 100, where higher scores reflect greater disease burden and poorer quality of life. Changes from baseline to Week 12 are assessed.

  5. Change in Functional Exercise Capacity Assessed by 6-Minute Walk Test (6MWT)

    Time frame: Baseline and post-intervention at Week 12

    Submaximal functional exercise capacity is assessed using the 6-Minute Walk Test (6MWT) administered in accordance with the 2022 American Thoracic Society (ATS) technical standards. The total distance walked in meters during 6 minutes is recorded. A longer distance indicates better functional physical capacity. Changes from baseline to Week 12 are assessed.

Study contacts

Contact information is provided by the study sponsor or research team.

MERYEM AKSARI GEDİKLİ, PT, MSc, PhD(c)

CONTACT

[email protected]

+90 531 208 15 15

Sponsors and collaborators

Lead sponsor

Saglik Bilimleri Universitesi

Other

Registry information

Official study title

Qigong Intervention for Fibromyalgia: Improving Spinal Mobility in Fibromyalgia Patients: A Randomized Controlled Pilot Study

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Sep 21, 2026
Registry last updated
Sep 21, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.